- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03224845
Courageous Parents, Courageous Children (COACH)
Transgenerational Prevention of Anxiety in Children at Ultra-high Risk
Anxiety disorders usually start in childhood and adolescence and are associated with social and occupational difficulties in adulthood. Children who have a parent with an anxiety disorder and who find new situations distressing and avoid them are at an increased risk for developing an anxiety disorder. Research suggests that anti-anxiety parenting can help children grow up courageous and calm. It is, however, difficult to parent in an anti-anxiety way when the parent has an anxiety disorder himself or herself.
This research study will test the efficacy of a new program designed to prevent the onset or persistence of anxiety disorders in children at risk for anxiety disorders. The investigators will first help parents learn skills to cope with their own anxiety and then coach them to share these skills with their children and parent in an anti-anxiety way. The goal is to intervene early enough in the children's lives so that they can be free of anxiety disorders and lead happy, healthy and productive lives in adulthood.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Parents:
Inclusion criteria:
Parents will be included if they have a current diagnosis of at least one anxiety disorder, one or more children between the ages two and eight years in their own care, capacity to provide informed consent, and ability to speak English well enough to benefit from the intervention.
Exclusion criteria:
Exclusion criteria for parents are receipt of an adequate course (6 or more sessions) of structured psychological therapy in the past 12 months, or plans to move out of Nova Scotia within the next three years. We will include parents with co-morbid mood disorders. However, those whose mood disorder is the primary complaint will be referred for treatment for their mood before being re-assessed. We will exclude parents with disorders that would interfere with the standard treatment protocol delivery; these include lifetime schizophrenia, autism, intellectual disability and current drug and alcohol use disorder.
Offspring:
Inclusion criteria:
Children are eligible if they are aged two to eight and if they have a score of inhibited temperament (negative emotionality) one standard deviation or more above the mean of an age-matched normative sample on the Laboratory Assessment of Temperament.
Exclusion criteria:
Those with lifetime schizophrenia, autism, general intellectual disability, and current drug and alcohol addiction will be excluded, as these conditions would impact on the standard delivery of the parenting intervention. We will exclude children currently receiving treatment for anxiety.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Cognitive behavioural skills training
|
The intervention will be delivered in two stages: First, the parent with an anxiety disorder will attend between six and sixteen weekly sessions of cognitive behavioural skills training focusing on their own anxiety.
They will work on developing behaviours that will help them become less anxious in the long-run and on learning to evaluate danger in a realistic way.
Next, the parent will take part in four to eight weekly sessions of anti-anxiety parenting skills training aiming to help them transfer the skills that they learned into parenting their children.
In the parenting intervention, the parents will be guided to gradually expose their children to new situations, build communication skills and confidence, in addition to general parenting skills and principles.
|
NO_INTERVENTION: No intervention
Participants in the control group will receive their usual clinical care and will not be discouraged from seeking any intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)
Time Frame: One year post randomization
|
Diagnosis of anxiety disorder in the offspring
|
One year post randomization
|
Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)
Time Frame: Two years post randomization
|
Diagnosis of anxiety disorder in the offspring
|
Two years post randomization
|
Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)
Time Frame: Three years post randomization
|
Diagnosis of anxiety disorder in the offspring
|
Three years post randomization
|
Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)
Time Frame: Five years post randomization
|
Diagnosis of anxiety disorder in the offspring
|
Five years post randomization
|
Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)
Time Frame: Seven years post randomization
|
Diagnosis of anxiety disorder in the offspring
|
Seven years post randomization
|
Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)
Time Frame: Ten years post randomization
|
Diagnosis of anxiety disorder in the offspring
|
Ten years post randomization
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Teaching Task Battery
Time Frame: One year post randomization
|
Parenting behaviours
|
One year post randomization
|
Teaching Task Battery
Time Frame: Two years post randomization
|
Parenting behaviours
|
Two years post randomization
|
Structured Clinical Interview for DSM-5 diagnoses (SCID-5)
Time Frame: One year post randomization
|
Diagnosis of anxiety disorder in the parent
|
One year post randomization
|
Structured Clinical Interview for DSM-5 diagnoses (SCID-5)
Time Frame: Two years post randomization
|
Diagnosis of anxiety disorder in the parent
|
Two years post randomization
|
Laboratory Temperament Assessment Battery
Time Frame: One year post randomization
|
Temperament in the offspring
|
One year post randomization
|
Laboratory Temperament Assessment Battery
Time Frame: Two years post randomization
|
Temperament in the offspring
|
Two years post randomization
|
Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)
Time Frame: Three years post randomization
|
Diagnosis of major mood and psychotic disorders in offspring
|
Three years post randomization
|
Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)
Time Frame: Five years post randomization
|
Diagnosis of major mood and psychotic disorders in offspring
|
Five years post randomization
|
Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)
Time Frame: Seven years post randomization
|
Diagnosis of major mood and psychotic disorders in offspring
|
Seven years post randomization
|
Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)
Time Frame: Ten years post randomization
|
Diagnosis of major mood and psychotic disorders in offspring
|
Ten years post randomization
|
Global Assessment of Functioning
Time Frame: One year post randomization
|
Functioning in the offspring
|
One year post randomization
|
Global Assessment of Functioning
Time Frame: Two years post randomization
|
Functioning in the offspring
|
Two years post randomization
|
Global Assessment of Functioning
Time Frame: Three years post randomization
|
Functioning in the offspring
|
Three years post randomization
|
Global Assessment of Functioning
Time Frame: Five years post randomization
|
Functioning in the offspring
|
Five years post randomization
|
Global Assessment of Functioning
Time Frame: Seven years post randomization
|
Functioning in the offspring
|
Seven years post randomization
|
Global Assessment of Functioning
Time Frame: Ten years post randomization
|
Functioning in the offspring
|
Ten years post randomization
|
Screen for Child Anxiety Related Disorders
Time Frame: One year post randomization
|
Anxiety in the offspring - continuous
|
One year post randomization
|
Screen for Child Anxiety Related Disorders
Time Frame: Two years post randomization
|
Anxiety in the offspring - continuous
|
Two years post randomization
|
Screen for Child Anxiety Related Disorders
Time Frame: Three years post randomization
|
Anxiety in the offspring - continuous
|
Three years post randomization
|
Screen for Child Anxiety Related Disorders
Time Frame: Five years post randomization
|
Anxiety in the offspring - continuous
|
Five years post randomization
|
Screen for Child Anxiety Related Disorders
Time Frame: Seven years post randomization
|
Anxiety in the offspring - continuous
|
Seven years post randomization
|
Screen for Child Anxiety Related Disorders
Time Frame: Ten years post randomization
|
Anxiety in the offspring - continuous
|
Ten years post randomization
|
Spence Children's Anxiety Scale
Time Frame: One year post randomization
|
Anxiety in the offspring - continuous
|
One year post randomization
|
Spence Children's Anxiety Scale
Time Frame: Two years randomization
|
Anxiety in the offspring - continuous
|
Two years randomization
|
Spence Children's Anxiety Scale
Time Frame: Three years post randomization
|
Anxiety in the offspring - continuous
|
Three years post randomization
|
Spence Children's Anxiety Scale
Time Frame: Five years post randomization
|
Anxiety in the offspring - continuous
|
Five years post randomization
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1022588
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety Disorder
-
Yale UniversityNational Institute of Mental Health (NIMH)Active, not recruitingGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
-
University of MichiganBrain & Behavior Research FoundationRecruitingGeneralized Anxiety Disorder | Anxiety | Social Anxiety Disorder | Panic DisorderUnited States
-
Baylor College of MedicineUniversity of PennsylvaniaRecruitingGeneralized Anxiety Disorder | Anxiety | Autism Spectrum Disorder | Separation Anxiety | Social Anxiety Disorder of ChildhoodUnited States
-
Erasmus Medical CenterTerminatedGeneralized Anxiety Disorder | Social Anxiety Disorder | Specific Phobia | Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood, Early OnsetNetherlands
-
Baylor College of MedicineRecruitingGeneralized Anxiety Disorder | Panic Disorder | Panic Disorder With Agoraphobia | Separation Anxiety | Anxiety Disorder of Childhood | Panic Attacks | Social Anxiety Disorder of Childhood | Obsessive-Compulsive Disorder in Children | Obsessive-Compulsive Disorder in AdolescenceUnited States
-
Daniel LiebermanTerminatedAnxiety | Anxiety Disorder SocialUnited States
-
Hospital de Clinicas de Porto AlegreUnknownGeneralized Anxiety Disorder | Social Anxiety Disorder | Separation Anxiety DisorderUnited States, Australia, Brazil, Israel
-
UCLH/UCL Joint Research OfficeMedical Research Council; Camden and Islington NHS Trust; Central and North West...RecruitingAnxiety Disorders | Anxiety | Anxiety Depression | CBT | Anxiety Disorders and Symptoms | Anxiety Generalized | Generalised Anxiety Disorder | Anxiety Disorder; Mixed With Depression (Mild) | Anxiety Disorder GeneralizedUnited Kingdom
-
Baylor College of MedicineRetirement Research Foundation; Archstone FoundationCompletedGeneralized Anxiety Disorder | Anxiety Disorder NOSUnited States
-
Wake Forest University Health SciencesNational Institute of Mental Health (NIMH)CompletedGeneralized Anxiety Disorder | Panic Disorder | Anxiety Disorder Not Otherwise Specified
Clinical Trials on Cognitive behavioural skills training
-
Sun Life Financial Movement Disorders Research...Unknown
-
VA Office of Research and DevelopmentCompletedSchizophrenia | Schizoaffective DisorderUnited States
-
Hamilton Health Sciences CorporationUnknownAutistic DisorderCanada
-
Vanderbilt UniversityRecruitingSchizophrenia | Social Skills | Schizo Affective DisorderUnited States
-
University of ZurichCompleted
-
Nova Scotia Health AuthorityCanadian Institutes of Health Research (CIHR); Nova Scotia Health Research...Recruiting
-
Hospital Clinic of BarcelonaUniversity of BarcelonaCompleted
-
Hartford HospitalNational Institute of Mental Health (NIMH)Completed
-
The University of Texas Health Science Center at...National Alliance for Research on Schizophrenia and DepressionCompletedSchizophrenia | SchizoaffectiveUnited States
-
National Institute of Diabetes and Digestive and...The Miriam HospitalCompletedObesity | OverweightUnited States